Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients
- Authors
- Noh, Jae Myoung; Choi, Doo Ho; Nam, Seok Jin; Lee, Jeong Eon; Kim, Jong Won; Kim, Sung-Won; Kang, Eunyoung; Lee, Min Hyuk; Ahn, Sei Hyun; Kim, Ku Sang; Park, Sue K.; Haffty, Bruce G.
- Issue Date
- Jan-2012
- Publisher
- Kluwer Academic Publishers
- Keywords
- Breast cancer; BRCA1 gene; BRCA2 gene; Heterozygote
- Citation
- Breast Cancer Research and Treatment, v.131, no.1, pp 217 - 222
- Pages
- 6
- Journal Title
- Breast Cancer Research and Treatment
- Volume
- 131
- Number
- 1
- Start Page
- 217
- End Page
- 222
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/15479
- DOI
- 10.1007/s10549-011-1718-5
- ISSN
- 0167-6806
1573-7217
- Abstract
- To investigate clinical, pathological, and familial characteristics of Korean patients with double heterozygosity for BRCA1 and BRCA2 mutations, six breast tumors of five patients who carried deleterious mutations in both of the genes were included. Medical records of the patients were reviewed and genetic testing by direct sequencing was undertaken to detect mutations in BRCA1 and BRCA2. Seven frameshift and three nonsense mutations were identified, and four mutations are novel in the Breast Cancer Information Core. There were no Ashkenazi founder mutations detected. The mean age at diagnosis for breast cancer was 33 years. All six tumors were infiltrating ductal carcinoma and poorly differentiated. Pathologic stage was I or II, and immunohistochemistry showed negative immunoreactivity for estrogen receptor and Her-2/neu in all tumors. Positive immunoreactivity for progesterone receptor was found only in one tumor. Three patients had familial history of breast, ovarian or other cancers. One patient who was diagnosed for breast cancer at the age of 26 had two maternal family members of metachronous bilateral breast cancer. Another patient who experienced metachronous bilateral breast cancer had maternal history of ovarian and esophageal cancer. In summary, Korean patients with double heterozygosity for BRCA1 and BRCA2 were young at diagnosis of breast cancer. Tumors were early stage, high grade, and almost triple-negative phenotype. All familial history of breast, ovary or other cancer was maternal. Close surveillance and accurate risk assessment should be provided for the patients with mutations in the both of the genes.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of General Surgery > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.